1. 1002TiPBAROCCO: A randomized phase II study of weekly paclitaxel vs cediranib-olaparib with continuous schedule vs cediranib-olaparib with intermittent schedule in advanced platinum resistant ovarian cancer. (23rd October 2018) Authors: Colombo, N; Nicoletto, O; Benedetti Panici, P; Tognon, G; Lissoni, A A; Bologna, A; Tomao, F; Fossati, R; Tettamanzi, F; Rulli, E; Galli, F; Alvisi, M F; Torri, V; Biagioli, E Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cancer incidence and mortality according to pre-existing heart failure in a community-based cohort. (14th October 2021) Authors: Bertero, E; Robusto, F; Rulli, E; D'Ettorre, A; Staszewsky, L; Maack, C; Lepore, V; Latini, R; Ameri, P Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of recent legislative bills regarding clinical research on Italian ethics committee activity. Issue 10 (30th September 2008) Authors: Porcu, L; Poli, D; Torri, V; Rulli, E; Di Tullio, M C; Cinquini, M; Bajetta, E; Labianca, R; Di Costanzo, F; Nitti, D; Floriani, I Journal: Journal of medical ethics Issue: Volume 34:Issue 10(2008) Page Start: 747 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P148 CANCER INCIDENCE AND MORTALITY ACCORDING TO PRE–EXISTING HEART FAILURE IN A COMMUNITY–BASED COHORT. (18th May 2022) Authors: Bertero, E; Robusto, F; Rulli, E; D'Ettore, A; Staszewsky, L; Maack, C; Lepore, V; Latini, R; Ameri, P Journal: European heart journal supplements Issue: Volume 24(2022)Supplement C Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗